Studying tumor budding in colorectal cancer
Part of Cancer clinical trials.
This trial looks at how small clusters of cancer cells at the edge of a tumor (called tumor budding) relate to colorectal cancer. This may help doctors better understand the cancer and plan the best treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with colorectal cancer.
- Your past tumor sample (tissue block) must have enough material for testing.
- Your doctors must have enough information about your diagnosis and treatment in your medical records.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures “minimal residual disease,” meaning tiny amounts of cancer that may remain after surgery, using blood samples. It may help doctors better detect who is at higher risk of cancer coming back and guide follow-up care.
This study looks at tissue samples from people with colorectal cancer to better understand tumor features and how they may respond to treatment. If you have colorectal cancer, the trial may help researchers match future treatments more effectively.
This study looks for blood/tumor signals (“biomarkers”) that may help predict outcomes in people whose colorectal cancer returns and spreads after surgery. It mainly helps researchers understand who may do better or worse, which can guide future care.
This study looks at special tiny cell-signal particles (called exosomes) and related pathways to understand colorectal cancer. Your results from samples may help researchers learn how these signals relate to the disease after surgery.
This study looks at how bacteria in your gut, your immune system, and colon cancer interact. It aims to understand these connections to improve future treatments.
This study looks at how gut bacteria and immune activity differ in normal, pre-cancer, and cancer colon tissue. It may help researchers understand what changes in the body are linked to colon growth and how they could be targeted in the future.
Hear when a new Colorectal Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.